{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T18:08:31Z","timestamp":1782410911010,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203135\/Z\/16\/Z"],"award-info":[{"award-number":["203135\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000866","name":"International AIDS Vaccine Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","award":["98341"],"award-info":[{"award-number":["98341"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","award":["96838"],"award-info":[{"award-number":["96838"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","award":["96825"],"award-info":[{"award-number":["96825"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["TMA2016SF-1535-CaTCH-22"],"award-info":[{"award-number":["TMA2016SF-1535-CaTCH-22"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001323","name":"Poliomyelitis Research Foundation","doi-asserted-by":"publisher","award":["PRF 21\/65"],"award-info":[{"award-number":["PRF 21\/65"]}],"id":[{"id":"10.13039\/501100001323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.xcrm.2022.100535","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T22:50:38Z","timestamp":1644447038000},"page":"100535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concern"],"prefix":"10.1016","volume":"3","author":[{"given":"Dale","family":"Kitchin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone I.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke A.","family":"van der Mescht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thopisang","family":"Motlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nonkululeko","family":"Mzindle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thandeka","family":"Moyo-Gwete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zanele","family":"Makhado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Ayres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelia P.","family":"Manamela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronwen","family":"Lambson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Oosthuysen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haajira","family":"Kaldine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marizane","family":"du Pisanie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilda","family":"Mennen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sango","family":"Skelem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noleen","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ntobeko A.B.","family":"Ntusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy A.","family":"Burgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda G.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda-Gail","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Boswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa M.","family":"Rossouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Ueckermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8719-4028","authenticated-orcid":false,"given":"Penny L.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2022.100535_bib1","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2022.100535_bib2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41586-021-03402-9","article-title":"Detection of a SARS-CoV-2 variant of concern in South Africa","volume":"592","author":"Tegally","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100535_bib3","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41591-021-01285-x","article-title":"SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma","volume":"27","author":"Wibmer","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2022.100535_bib4","article-title":"Antibody response and variant cross-neutralization after SARS-CoV-2 breakthrough infection","author":"Bates","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.xcrm.2022.100535_bib5","article-title":"Immune responses in fully vaccinated individuals following breakthrough infection with the SARS-CoV-2 Delta variant in Provincetown, Massachusetts","author":"Collier","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.xcrm.2022.100535_bib6","article-title":"Delta breakthrough infections elicit potent, broad and durable neutralizing antibody responses","author":"Walls","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2022.100535_bib7","article-title":"Rapid\u00a0epidemic expansion of the SARS-CoV-2 Omicron variant in Southern\u00a0Africa","author":"Viana","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.xcrm.2022.100535_bib8","article-title":"Rapid replacement of the beta variant by the delta variant in South Africa","author":"Tegally","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.xcrm.2022.100535_bib9","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1001\/jama.2021.3645","article-title":"Immunogenicity of the Ad26.COV2.S vaccine for COVID-19","volume":"325","author":"Stephenson","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.xcrm.2022.100535_bib10","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1056\/NEJMc2108829","article-title":"Durable humoral and cellular immune responses 8\u00a0months after Ad26.COV2.S vaccination","volume":"385","author":"Barouch","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2022.100535_bib11","article-title":"Durability of antibody responses elicited by a single dose of Ad26.COV2.S and substantial increase following late boosting","author":"Sadoff","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.xcrm.2022.100535_bib12","article-title":"A novel variant of interest of SARS-CoV-2 with multiple spike mutations detected through travel surveillance in Africa","author":"de Oliveira","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.xcrm.2022.100535_bib13","article-title":"Emergence and phenotypic characterization of C.1.2, a globally detected lineage that rapidly accumulated mutations of concern","author":"Scheepers","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.xcrm.2022.100535_bib14","article-title":"Ad26.COV2.S elicited neutralizing activity against delta and other SARS-CoV-2 variants of concern","author":"Jongeneelen","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2022.100535_bib15","first-page":"1","article-title":"Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans","author":"Alter","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100535_bib16","article-title":"Comparison of neutralizing antibody titers elicited by mRNA and adenoviral vector vaccine against SARS-CoV-2 variants","author":"Tada","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2022.100535_bib17","article-title":"Neutralization of Mu and C.1.2 SARS-CoV-2 variants by vaccine-elicited antibodies in individuals with and without previous history of infection","author":"Tada","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2022.100535_bib18","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.cell.2020.10.052","article-title":"Compromised humoral functional evolution tracks with SARS-CoV-2 mortality","volume":"183","author":"Zohar","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2022.100535_bib19","article-title":"A SARS-CoV-2 variant of concern triggers Fc effector function with\u00a0increased cross-reactivity","author":"Richardson","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.xcrm.2022.100535_bib20","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.chom.2021.10.003","article-title":"Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant dependent manner","volume":"29","author":"Keeton","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2022.100535_bib21","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1056\/NEJMoa2105000","article-title":"Vaccine breakthrough infections with SARS-CoV-2 variants","volume":"384","author":"Hacisuleyman","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2022.100535_bib22","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.immuni.2021.07.008","article-title":"Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations","volume":"54","author":"Muecksch","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2022.100535_bib23","first-page":"1","article-title":"Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100535_bib24","doi-asserted-by":"crossref","first-page":"103748","DOI":"10.1016\/j.ebiom.2021.103748","article-title":"Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: impact of prior exposure and sex","volume":"74","author":"Tang","year":"2021","journal-title":"eBioMedicine"},{"key":"10.1016\/j.xcrm.2022.100535_bib25","article-title":"South African population immunity and severe covid-19 with Omicron variant","author":"Madhi","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.xcrm.2022.100535_bib26","article-title":"Vaccine effectiveness against hospital admission in South African health care workers who received a homologous booster of Ad26.COV2 during an Omicron COVID19 wave: preliminary results of the Sisonke 2 study","author":"Gray","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.xcrm.2022.100535_bib27","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/s41564-021-00947-3","article-title":"Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom","volume":"6","author":"Wei","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.xcrm.2022.100535_bib28","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1056\/NEJMc2104192","article-title":"Cross-reactive neutralizing antibody responses elicited by SARS-CoV-2 501Y.V2 (B.1.351)","volume":"384","author":"Moyo-Gwete","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2022.100535_bib29","doi-asserted-by":"crossref","first-page":"e13088","DOI":"10.1111\/sji.13088","article-title":"Advances in neutralization assays for SARS-CoV-2","volume":"94","author":"Lu","year":"2021","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.xcrm.2022.100535_bib30","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41577-020-00471-1","article-title":"Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models","volume":"20","author":"Khoury","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2022.100535_bib31","doi-asserted-by":"crossref","first-page":"e20201181","DOI":"10.1084\/jem.20201181","article-title":"Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses","volume":"217","author":"Schmidt","year":"2020","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2022.100535_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/vaccines9010013","article-title":"Comparison of four SARS-CoV-2 neutralization assays","volume":"9","author":"Riepler","year":"2021","journal-title":"Vaccines"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379122000350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379122000350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:14:15Z","timestamp":1778919255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379122000350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2666379122000350"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2022.100535","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.11.08.21266049","asserted-by":"object"}]},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concern","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2022.100535","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"100535"}}